1. HBW Insight
  2. >>Wellness
  3. >>Business

CVS Trims 7% Of Supplements From Its Shelves In 'Tested To Be Trusted' Program

 
• By Eileen Francis

CVS implemented “Tested to be Trusted” third-party program for supplements six months ahead of schedule, reducing products at store shelves 7%. National drug chain confirms it will roll out more than 300 health and wellness products across six additional categories.

Anderson - Circa November 2016: CVS Pharmacy Retail Location. CVS is the Largest Pharmacy Chain in the US VI - Image

CVS Pharmacy has room for more than 300 health and wellness products in additional categories after it removed 7% of the 1,400 vitamins, minerals and supplements it was offering based on results from a third-party testing program.

The national drug chain's “Tested to be Trusted” program requires third-party testing of all VMS products sold in stores and online to confirm the accuracy of ingredients listed on supplement...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

IQVIA Consumer Health: Digestive Category Driving Global OTC Market Growth

 
• By David Ridley

An increasing awareness of and interest in gut health helped the global OTC market grow by 4.6% in value terms in 2024, according to IQVIA Consumer Health.

Dermapharm Seeks To Put Stop To Spanish Slide

 
• By Tom Gallen

Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By Tom Gallen

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By Tom Gallen

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.

More from Wellness

US FDA Supplement Office Chief Eyes ‘Movement’ This Year On NDI Notifications Final Guidance

 
• By Malcolm Spicer

“We've made some progress and really hope to see some movement as we move forward this year,” says FDA Office of Dietary Supplement Programs director Cara Welch.

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By Tom Gallen

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By Tom Gallen

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.